Preora Diagnostics to Commercialize Cancer Pre-screening Tests

NanoCytomics LLC today announced the formation of Preora Diagnostics Inc., a privately held medical technology company that will bring low-cost cancer pre-screening tests to primary care physicians in the U.S. and other select markets. Click here to learn more. Preora Launch Release.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut maximus imperdiet leo, non mattis neque laoreet eu. Nunc vitae nisi augue. Vestibulum hendrerit nulla aliquet sapien egestas, non interdum mauris sagittis. In nec neque ut libero interdum vehicula. Nulla eros est, gravida eget sem sit amet, condimentum sodales lacus. Vestibulum et imperdiet dolor. Nullam volutpat leo risus, sit amet ullamcorper odio sodales ac. In eu quam scelerisque, tincidunt nulla vel, elementum dolor. Aliquam malesuada, tortor sit amet rhoncus convallis, eros sem placerat massa, vitae pellentesque turpis ipsum vel eros. Aliquam erat volutpat. Donec convallis lacus a nisl facilisis, vitae condimentum libero ultrices. Suspendisse id eleifend risus. Nunc mattis sit amet justo ac lobortis. Ut tempus dui vitae odio pulvinar pharetra. Lorem ipsum dolor sit amet, consectetur adipiscing elit.